CELIAC DISEASE FOUNDATION – Celiac Disease Foundation 2022 Bid for a Cure Auction
Auction Ends: Jul 25, 2022 06:00 PM PDT


European Celiac Cruise for Two, 100% Dedicated Gluten-Free

Item Number
Estimated Value
$10,658 USD
Opening Bid
$7,999 USD

The winning bid will go to FrontStream Global Fund (tax ID 26-3265577), a 501c3 nonprofit organization, which will send the donation to CELIAC DISEASE FOUNDATION (tax ID 954310830) on behalf of the winner.

Item Description

From the gluten-free dining room to exclusive events and activities just for Celiac Cruise guests, Celiac Cruise offers a cruise vacation for the gluten-free community. 

This includes a French Balcony cabin for two aboard the European Sailing that will start in Vilshofen, Germany and conclude in Budapest, Hungary. The cruise will depart on October 30, 2022 and return November 6, 2022. 

Your 7-night all-inclusive experience includes
-Luxury accommodations onboard the AmaLea.
-All gluten-free meals and wine, gluten-free beer, and non-alcoholic beverages onboard.
-100% gluten-free menus
-Additional dietary restrictions can be accomodated (communicate your needs with travel specialist at time of booking) 
-Excursions in each port of call for all activity levels, including castles, museums, bike tours and more.
-Immersive tours into the rich history of Europe.
-Gluten-free food tastings & pairings.
-Gluten-free Oktoberfest party with live music, GF beer, soft pretzels, AND MORE! 
-Educational opportunities with medical and community leaders.

Terms and Conditions

-Package does not include airfare, port taxes ($210 per person), gratuities ($157 per person), or travel insurance, which must be purchased separately. 

-Upgrade options available for an additional price based on availability.

-Winning bidder and travel companions agree to adhere to all destination(s) travel restrictions and requirements. 

-In the event the sailing is canceled due to unforeseen circumstances, this is valid for one cabin in a future Celiac Cruise sailing through December 31, 2025.